Alphabetic Index FY2027

E09.35

Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy

FY2027Chapter 4: Endocrine, nutritional and metabolic diseases/E08–E13 Diabetes mellitus

Non-billable headerNot valid on its own. Use one of the more specific codes under it.

E09.35 is a non-billable ICD-10-CM code header for drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy. Report a more specific code from it instead. It is part of the FY2027 code set, effective October 1, 2026. The more specific codes under it are E09.351 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema, E09.352 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, E09.353 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, E09.354 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment and 2 more. Its coding notes include a Code first instruction, a Use additional code instruction and 9 Excludes1 entries.

7th characters

Every code below needs one of these.

One of the following 7th characters is to be assigned to codes in subcategory E09.35 to designate laterality of the disease:

  • 1right eye
  • 2left eye
  • 3bilateral
  • 9unspecified eye

Guidelines tips

From the FY2027 Official Guidelines. ICD10Ref adds no rules of its own.

Diabetes codes combine the type, the body system and the complication, and as many codes as needed are assigned to describe all complications.

Guidelines I.C.4.aDiabetes: combination codesRead the official text

Secondary diabetes is always caused by another condition or event. Sequencing with the cause follows the Tabular List instructions.

Guidelines I.C.4.a.6Secondary diabetes mellitusRead the official text

Code first

If the underlying condition listed here is present and known, sequence it first.

Inherited from E09 Drug or chemical induced diabetes mellitus
  • poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4)

Use additional code

Add the listed code as a secondary code, if known.

Inherited from E09 Drug or chemical induced diabetes mellitus
  • code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
  • code to identify control using:
    • injectable non-insulin antidiabetic drugs (Z79.85)
    • insulin (Z79.4)
    • oral antidiabetic drugs (Z79.84)
    • oral hypoglycemic drugs (Z79.84)

Excludes1

Not coded here. The listed conditions generally should not be reported together.

Inherited from E09 Drug or chemical induced diabetes mellitus
  • diabetes mellitus due to underlying condition (E08.-)
  • gestational diabetes (O24.4-)
  • neonatal diabetes mellitus (P70.2)
  • postpancreatectomy diabetes mellitus (E13.-)
  • postprocedural diabetes mellitus (E13.-)
  • secondary diabetes mellitus NEC (E13.-)
  • type 1 diabetes mellitus (E10.-)
  • type 2 diabetes mellitus (E11.-)
Also from chapter/block level (1 note)
Inherited from Chapter 4 Endocrine, nutritional and metabolic diseases
  • transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Notes

Also from chapter/block level (1 note)
Inherited from Chapter 4 Endocrine, nutritional and metabolic diseases
  • All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.

More specific codes under E09.35 6